One in Five Undergoing Telemetry for Noncardiac Indications

Share this content:
One in Five Undergoing Telemetry for Noncardiac Indications
One in Five Undergoing Telemetry for Noncardiac Indications

FRIDAY, Feb. 3, 2017 (HealthDay News) -- More than 20 percent of patients undergoing telemetry have noncardiac indications, according to a study published online Jan. 27 in the Journal of Evaluation in Clinical Practice.

Stephanie Chen, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues conducted a retrospective study to examine provider ordering practices for telemetry at a U.S.-based academic hospital. Indications were categorized per the American Heart Association guidelines.

The researchers found that the top three cardiac indications included angina/acute coronary syndrome, arrhythmias, and heart failure (35.3, 19.7, and 10.2 percent, respectively). Overall, 20.2 percent of orders were for noncardiac indications, including respiratory conditions, infection, substance abuse, bleeding, vital sign monitoring, altered mental status, and pulmonary embolus/deep vein thrombosis (17.4, 17.4, 14.0, 12.4, 10.4, 7.0, and 7.0 percent, respectively).

"One-fifth of patients were monitored on telemetry for noncardiac indications," the authors write. "We recommend further study on the benefits and risks of telemetry in these patients and systems-based changes for appropriate usage."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Congress Approves Bill Expanding Private Care for VA Patients

Congress Approves Bill Expanding Private Care for VA ...

New bill would open up access to private doctors for veterans

AAP Recommending Injectable Flu Shot for 2018-19 Flu Season

AAP Recommending Injectable Flu Shot for 2018-19 Flu ...

Children should receive injectable vaccine, which has been shown to be more consistently effective

Neurologists Identify New Type of Vertigo

Neurologists Identify New Type of Vertigo

Long-term prognosis favorable, with improvement of symptoms in more than half of patients